Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David P Enot

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Science (New York, N.Y.)|November 7, 2015
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaMarie Vétizou, Jonathan M Pitt, Romain Daillère, et al.
Science (New York, N.Y.)|October 31, 2015
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Nature Communications|February 21, 2019
The flavonoid 4,4'-dimethoxychalcone promotes autophagy-dependent longevity across speciesDidac Carmona-Gutierrez, Andreas Zimmermann, Katharina Kainz, et al.
Nature Medicine|October 27, 2014
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapyAntonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Science (New York, N.Y.)|November 7, 2015
Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiotaMarie Vétizou, Jonathan M Pitt, Romain Daillère, et al.
Science (New York, N.Y.)|October 31, 2015
Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1Erika Vacchelli, Yuting Ma, Elisa E Baracco, et al.
Nature Communications|February 21, 2019
The flavonoid 4,4'-dimethoxychalcone promotes autophagy-dependent longevity across speciesDidac Carmona-Gutierrez, Andreas Zimmermann, Katharina Kainz, et al.
Nature Medicine|October 27, 2014
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapyAntonella Sistigu, Takahiro Yamazaki, Erika Vacchelli, et al.
Pageof 4